ARVINAS, INC. ARVN
- luxdegalutamide — Metastatic Castration-Resistant Prostate Cancer Phase 3
- luxdegalutamide — Prostate Cancer Phase 1
- bavdegalutamide
Home › Targets › androgen receptor
androgen receptor (3 companies · 6 programs)
Companies with an active program directed at androgen receptor.
Viking Therapeutics, Inc. VKTX
- VK5211 — Hip Fracture Phase 2
- VK5211 Phase 2
Fortress Biotech, Inc. FBIO
- AJ201